Search research articles
Contact Us
Filters
Showing results (521-530 of 532) with videos related to
Page
of 54
Sort By:
Immunological Reviews
|
January 4, 2001
Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation
D Huang, Y Han, M R Rani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2008
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients
P L Zinzani, M Tani, S Fanti, et al.
Clinics (Sao Paulo, Brazil)
|
May 29, 2015
Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases
Aline Lopes Chagas, Luciana Kikuchi, Paulo Herman, et al.
Journal of Neuroimmunology
|
July 17, 1999
Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors
V A Folcik, T Smith, S O'Bryant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2011
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma
P L Zinzani, M Tani, A Pulsoni, et al.
American Journal of Clinical Oncology
|
October 1, 2014
Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System
Luciana Kikuchi, Claudia P Oliveira, Mario R Alvares-da-Silva, et al.
Seminars in Oncology
|
April 1, 1997
Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan
S Kawai, M Tani, J Okamura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients
P L Zinzani, F Gherlinzoni, S Storti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2023
Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial
M Ladetto, R Tavarozzi, M Zanni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2024
Corrigendum to "Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma": [Ann Oncol 35 (2024) 1039-1047]
T M Kim, M Taszner, S Novelli, et al.
Page
of 54
Search research articles
Search
Showing results (521-530 of 532) with videos related to
Sort By:
Page
of 54
Immunological Reviews
|
January 4, 2001
Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation
D Huang, Y Han, M R Rani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2008
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients
P L Zinzani, M Tani, S Fanti, et al.
Clinics (Sao Paulo, Brazil)
|
May 29, 2015
Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases
Aline Lopes Chagas, Luciana Kikuchi, Paulo Herman, et al.
Journal of Neuroimmunology
|
July 17, 1999
Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors
V A Folcik, T Smith, S O'Bryant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2011
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma
P L Zinzani, M Tani, A Pulsoni, et al.
American Journal of Clinical Oncology
|
October 1, 2014
Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System
Luciana Kikuchi, Claudia P Oliveira, Mario R Alvares-da-Silva, et al.
Seminars in Oncology
|
April 1, 1997
Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan
S Kawai, M Tani, J Okamura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients
P L Zinzani, F Gherlinzoni, S Storti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2023
Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial
M Ladetto, R Tavarozzi, M Zanni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2024
Corrigendum to "Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma": [Ann Oncol 35 (2024) 1039-1047]
T M Kim, M Taszner, S Novelli, et al.
Page
of 54